Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, signaling a new version of the page or its template; this is a technical update rather than a substantive modification to the study details.SummaryDifference0.0%

- Check35 days agoChange DetectedThe study page now displays a recruitment-closed notice ('No longer looking for participants') and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the page revision tag to v3.6.0 and standardizes the Intervention/Treatment label.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page's revision label has been updated to Revision: v3.5.5, replacing Revision: v3.5.4. This indicates an update to the page's underlying documents or templates.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.4 is now shown, replacing the previous revision v3.5.3; this denotes a minor version update to the page rather than a content change.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change in the site release rather than the underlying study information.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.